Literature DB >> 26037332

Role of the satiety factor oleoylethanolamide in alcoholism.

Ainhoa Bilbao1,2, Antonia Serrano1,3, Andrea Cippitelli4, Francisco J Pavón1,3, Andrea Giuffrida5, Juan Suárez1, Nuria García-Marchena1,6, Elena Baixeras1, Raquel Gómez de Heras6, Laura Orio6, Francisco Alén6, Roberto Ciccocioppo4, Benjamin F Cravatt7, Loren H Parsons3, Daniele Piomelli8,9, Fernando Rodríguez de Fonseca1,6.   

Abstract

Oleoylethanolamide (OEA) is a satiety factor that controls motivational responses to dietary fat. Here we show that alcohol administration causes the release of OEA in rodents, which in turn reduces alcohol consumption by engaging peroxisome proliferator-activated receptor-alpha (PPAR-α). This effect appears to rely on peripheral signaling mechanisms as alcohol self-administration is unaltered by intracerebral PPAR-α agonist administration, and the lesion of sensory afferent fibers (by capsaicin) abrogates the effect of systemically administered OEA on alcohol intake. Additionally, OEA is shown to block cue-induced reinstatement of alcohol-seeking behavior (an animal model of relapse) and reduce the severity of somatic withdrawal symptoms in alcohol-dependent animals. Collectively, these findings demonstrate a homeostatic role for OEA signaling in the behavioral effects of alcohol exposure and highlight OEA as a novel therapeutic target for alcohol use disorders and alcoholism.
© 2015 Society for the Study of Addiction.

Entities:  

Keywords:  Alcohol self-administration; PPAR-α; alcoholism; oleoylethanolamide; relapse

Mesh:

Substances:

Year:  2015        PMID: 26037332      PMCID: PMC4668242          DOI: 10.1111/adb.12276

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  50 in total

1.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

3.  Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.

Authors:  Ainhoa Bilbao; Eduardo Blanco; María Jesús Luque-Rojas; Juan Suárez; Ana Palomino; Margarita Vida; Pedro Araos; Francisco J Bermúdez-Silva; Emilio Fernández-Espejo; Rainer Spanagel; Fernando Rodríguez de Fonseca
Journal:  Addict Biol       Date:  2012-11-19       Impact factor: 4.280

4.  The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.

Authors:  Silvana Gaetani; Jin Fu; Tommaso Cassano; Pasqua Dipasquale; Adele Romano; Laura Righetti; Silvia Cianci; Leonardo Laconca; Elisa Giannini; Sergio Scaccianoce; Jérôme Mairesse; Vincenzo Cuomo; Daniele Piomelli
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

5.  Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.

Authors:  Jin Fu; Giuseppe Astarita; Silvana Gaetani; Janet Kim; Benjamin F Cravatt; Ken Mackie; Daniele Piomelli
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

6.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

7.  Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.

Authors:  Anita C Hansson; Francisco J Bermúdez-Silva; Hanna Malinen; Petri Hyytiä; Irene Sanchez-Vera; Roberto Rimondini; Fernando Rodriguez de Fonseca; George Kunos; Wolfgang H Sommer; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2006-02-08       Impact factor: 7.853

8.  Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.

Authors:  Margarita Suardíaz; Guillermo Estivill-Torrús; Carlos Goicoechea; Ainhoa Bilbao; Fernando Rodríguez de Fonseca
Journal:  Pain       Date:  2007-04-20       Impact factor: 6.961

9.  Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane.

Authors:  B S Basavarajappa; T B Cooper; B L Hungund
Journal:  Brain Res       Date:  1998-05-18       Impact factor: 3.252

10.  Fat-induced satiety factor oleoylethanolamide enhances memory consolidation.

Authors:  Patrizia Campolongo; Benno Roozendaal; Viviana Trezza; Vincenzo Cuomo; Giuseppe Astarita; Jin Fu; James L McGaugh; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

View more
  21 in total

1.  Fatty acid amide supplementation decreases impulsivity in young adult heavy drinkers.

Authors:  Maria J van Kooten; Maria G Veldhuizen; Ivan E de Araujo; Stephanie S O'Malley; Dana M Small
Journal:  Physiol Behav       Date:  2015-11-30

2.  In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.

Authors:  Asti Jackson; Deniz Bagdas; Pretal P Muldoon; Aron H Lichtman; F Ivy Carroll; Mark Greenwald; Michael F Miles; M Imad Damaj
Journal:  Neuropharmacology       Date:  2017-03-07       Impact factor: 5.250

3.  Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice.

Authors:  Francisco J Pavón; Antonia Serrano; David G Stouffer; Ilham Polis; Marisa Roberto; Benjamin F Cravatt; Rémi Martin-Fardon; Fernando Rodríguez de Fonseca; Loren H Parsons
Journal:  Addict Biol       Date:  2018-11-13       Impact factor: 4.280

4.  Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala.

Authors:  Juan Suárez; Sophia Khom; Francisco Alén; Luis A Natividad; Florence P Varodayan; Reesha R Patel; Dean Kirson; Rocío Arco; Antonio Ballesta; Michal Bajo; Leticia Rubio; Rémi Martin-Fardon; Fernando Rodríguez de Fonseca; Marisa Roberto
Journal:  Addict Biol       Date:  2019-07-24       Impact factor: 4.280

Review 5.  Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies.

Authors:  Cynthia J M Kane; Paul D Drew
Journal:  J Leukoc Biol       Date:  2016-07-26       Impact factor: 4.962

6.  Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide.

Authors:  M Antón; A Rodríguez-González; A Ballesta; N González; A Del Pozo; F R de Fonseca; M L Gómez-Lus; J C Leza; B García-Bueno; J R Caso; L Orio
Journal:  Br J Pharmacol       Date:  2018-10-29       Impact factor: 8.739

Review 7.  Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.

Authors:  Massimo Ubaldi; Nazzareno Cannella; Roberto Ciccocioppo
Journal:  Prog Brain Res       Date:  2015-11-26       Impact factor: 2.453

8.  N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.

Authors:  Yannick Fotio; Roberto Ciccocioppo; Daniele Piomelli
Journal:  Psychopharmacology (Berl)       Date:  2020-10-10       Impact factor: 4.530

Review 9.  Immune treatments for alcohol use disorder: A translational framework.

Authors:  Lindsay R Meredith; Elizabeth M Burnette; Erica N Grodin; Michael R Irwin; Lara A Ray
Journal:  Brain Behav Immun       Date:  2021-07-31       Impact factor: 19.227

10.  Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats.

Authors:  Francisco Javier Pavón; Eva María Marco; Mariam Vázquez; Laura Sánchez; Patricia Rivera; Ana Gavito; Virginia Mela; Francisco Alén; Juan Decara; Juan Suárez; Elena Giné; José Antonio López-Moreno; Julie Chowen; Fernando Rodríguez-de-Fonseca; Antonia Serrano; María Paz Viveros
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.